European Federation of Allergy and Airways Diseases Patients' Associations (EFA)

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is the voice of over 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe.

The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) represents the voice of patients living with allergy, asthma and chronic obstructive pulmonary disease (COPD) in Europe. On the occasion of the revision of the Energy Performance of Buildings Directive (EPBD), EFA highlights the importance of addressing Indoor Air Quality, a key environmental determinant of health accounting for 10%…

The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) represents the 200 million people living with allergy, asthma and chronic obstructive pulmonary disease (COPD) in Europe. We fully acknowledge that renovations can drive the transition towards green buildings but also healthy living environments, reducing disease risk factors and allowing vulnerable groups of the population.

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. We bring together 45 national associations from 26 countries.

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. We bring together 45 national associations from 26 countries.

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. We connect European stakeholders to ignite change and bridge the policy gaps in allergy and airways diseases so that patients live uncompromised lives, have the right and access to the best quality care and a…

The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) welcomes the Commission initiative for a European Health Data Space, and especially its provisions related to the primary use of data. Regarding particular aspects of the proposed regulation, EFA fully agrees with the contribution of the European Patient Forum (EPF) on the need to put in place a policy framework that ensures: 1.

We welcome the initiative of the European Commission to setup a European Health Data Space (EHDS). As the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe, the European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) fully acknowledges the immense benefits that data sharing applied to health can bring to people’s diagnosis…

EFA welcomes the determination of the European Commission to reduce greenhouse emissions generated in the European Union. Climate change negatively affects human health, and more especially the health of vulnerable people such as allergy, asthma and COPD patients. Asthma affects 30 million children and adults under 45 years of age in Europe and it is estimated that COPD affects 10% of the European population.

The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is the voice of over 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe.

The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) welcomes the opportunity to contribute to the call for evidence for a European Climate Resilience and Risk Management, meant to inform an integrated framework for climate adaptation to be adopted in 2026.

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) considers the revision of the EU Ambient Air Quality Directives (AAQD) as a crucial step to correct existing shortcomings and gaps in the current air quality legislative framework which lead to the development of allergy and respiratory disease and cause 300,000 deaths annually.

The European Federation of Allergy and Airways Diseases Patients' Associations (EFA) welcomes the initiative of the Commission to revise the Ambient Air Quality Directives. Air pollution remains the single largest environmental health risk in Europe, and a major cause of mortality responsible for around 400.000 premature deaths per year.

The European Federation of Allergy and Airways Diseases Patients Associations (EFA) is supportive of creating a new legal form for associations allowing for recognition in all Member States, as long as it is developed in close consultation with a diverse community of Non-Profit Organisations (NPOs) across the EU to ensure benefits and avoid unforeseen negative impacts.

The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. EFA is member at the EMA Patients’ and Consumers’ Working Party (PCWP), therefore having first-hand experience of the agency’s strong engagement with stakeholders.

The European Federation of Allergy and Airways Diseases Patients’ Associations (EFA) is the voice of 200 million people living with allergy, asthma, and chronic obstructive pulmonary disease (COPD) in Europe. EFA is member at the EMA Patients’ and Consumers’ Working Party (PCWP), therefore having first-hand experience of the agency’s strong engagement with stakeholders.